CHRONIC LYMPHOCYTIC LEUKEMIA OR SMALL LYMPHOCYTIC LYMPHOMA
Clinical trials for CHRONIC LYMPHOCYTIC LEUKEMIA OR SMALL LYMPHOCYTIC LYMPHOMA explained in plain language.
Never miss a new study
Get alerted when new CHRONIC LYMPHOCYTIC LEUKEMIA OR SMALL LYMPHOCYTIC LYMPHOMA trials appear
Sign up with your email to follow new studies for CHRONIC LYMPHOCYTIC LEUKEMIA OR SMALL LYMPHOCYTIC LYMPHOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New combo aims to reduce dangerous side effect in blood cancer treatment
Disease control OngoingThis early-phase study tests whether giving rituximab and high-dose steroids before venetoclax can safely lower the number of cancer cells in people with relapsed or refractory chronic lymphocytic leukemia (CLL) or small lymphocytic lymphoma (SLL). The goal is to reduce the risk …
Matched conditions: CHRONIC LYMPHOCYTIC LEUKEMIA OR SMALL LYMPHOCYTIC LYMPHOMA
Phase: PHASE1 • Sponsor: University of California, San Diego • Aim: Disease control
Last updated May 26, 2026 08:19 UTC
-
New drug combo battle: which works better for blood cancer?
Disease control OngoingThis study compares two drug combinations for people with untreated chronic lymphocytic leukemia or small lymphocytic lymphoma. About 600 participants will receive either acalabrutinib plus venetoclax or venetoclax plus obinutuzumab. The goal is to see which combination better co…
Matched conditions: CHRONIC LYMPHOCYTIC LEUKEMIA OR SMALL LYMPHOCYTIC LYMPHOMA
Phase: PHASE3 • Sponsor: AstraZeneca • Aim: Disease control
Last updated May 22, 2026 14:03 UTC